Literature DB >> 18465443

Adult mesenchymal stromal stem cells for therapeutic applications.

D Spitkovsky1, J Hescheler.   

Abstract

Mesenchymal stromal stem cells (MSC) can be found in almost any adult organ. They can be isolated and expanded within several weeks up to hundreds of millions of cells. The cell isolation based on the surface antigen expression may significantly enrich for the desired cell population and reduce the time required for cell expansion. MSC display a unique molecular signature which clearly discriminates them from other stem cell types. MSC can be differentiated into the cells of several lineages. Additionally, the unique biological properties of MSC are mediated by strong immunomodulatory activity and by paracrine mechanisms. Potential therapeutic applications of the cells require clinically compliant protocols for cell isolation and expansion. The therapeutic utility of MSC has been evaluated and found to be useful in several pre-clinical animal models as well as in clinical trials.

Mesh:

Year:  2008        PMID: 18465443     DOI: 10.1080/13645700801969758

Source DB:  PubMed          Journal:  Minim Invasive Ther Allied Technol        ISSN: 1364-5706            Impact factor:   2.442


  8 in total

1.  Stem cells to the rescue.

Authors:  Lawrence R Schiller
Journal:  Curr Gastroenterol Rep       Date:  2008-10

2.  Characterization of adipose-derived equine and canine mesenchymal stem cells after incubation in agarose-hydrogel.

Authors:  Christina Schwarz; Uta Leicht; Inga Drosse; Veronika Ulrich; Volker Luibl; Matthias Schieker; Michael Röcken
Journal:  Vet Res Commun       Date:  2011-07-15       Impact factor: 2.459

3.  Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging.

Authors:  Shannon Kidd; Erika Spaeth; Jennifer L Dembinski; Martin Dietrich; Keri Watson; Ann Klopp; Venkata Lokesh Battula; Micheal Weil; Michael Andreeff; Frank C Marini
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

Review 4.  Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease.

Authors:  Scott D Olson; Kari Pollock; Amal Kambal; Whitney Cary; Gaela-Marie Mitchell; Jeremy Tempkin; Heather Stewart; Jeannine McGee; Gerhard Bauer; Hyun Sook Kim; Teresa Tempkin; Vicki Wheelock; Geralyn Annett; Gary Dunbar; Jan A Nolta
Journal:  Mol Neurobiol       Date:  2011-12-09       Impact factor: 5.590

5.  Intrapleural delivery of MSCs attenuates acute lung injury by paracrine/endocrine mechanism.

Authors:  Zhao-hui Qin; Jin-fu Xu; Jie-ming Qu; Jing Zhang; Yin Sai; Chun-mei Chen; Lian Wu; Long Yu
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

6.  Comparison of enzymatic and non-enzymatic means of dissociating adherent monolayers of mesenchymal stem cells.

Authors:  Boon C Heng; Catherine M Cowan; Shubhayu Basu
Journal:  Biol Proced Online       Date:  2009-03-10       Impact factor: 3.244

7.  Er-Xian Decoction Stimulates Osteoblastic Differentiation of Bone Mesenchymal Stem Cells in Ovariectomized Mice and Its Gene Profile Analysis.

Authors:  Shufen Liu; Jianhua Huang; Jing Wang; Yongjian Zhao; Sheng Lu; Yongjun Wang; Qin Bian
Journal:  Stem Cells Int       Date:  2016-03-15       Impact factor: 5.443

8.  The regulatory mechanism of p38/MAPK in the chondrogenic differentiation from bone marrow mesenchymal stem cells.

Authors:  Ning Ma; Xiao Teng; Qi Zheng; Peng Chen
Journal:  J Orthop Surg Res       Date:  2019-12-12       Impact factor: 2.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.